Francesco Baudo

Summary

Affiliation: Catholic University
Country: Italy

Publications

  1. doi request reprint Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
    Francesco Baudo
    Thrombosis and Hemostasis Unit, Ospedale Niguarda, Milan, Italy
    Blood 120:39-46. 2012
  2. pmc Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
    Peter Collins
    Arthur Bloom Hemophilia centre, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK
    BMC Res Notes 3:161. 2010
  3. ncbi request reprint "Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue
    Francesco Baudo
    Haemostasis and Thrombosis Unit, Niguarda Ca Granda Hospital, Milan, Italy
    Intern Emerg Med 1:94-5. 2006
  4. ncbi request reprint Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study
    F Baudo
    Department of Hematology, Ospedale Niguarda, Milano, Italy
    Intensive Care Med 24:336-42. 1998
  5. ncbi request reprint Acquired hemophilia: a critical bleeding syndrome
    Francesco Baudo
    Department of Hematology and Thrombosis Hemostasis Unit, Niguarda Hospital, Milan, Italy
    Haematologica 89:96-100. 2004
  6. ncbi request reprint [Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects]
    F Baudo
    Modulo Trombosi ed Emostasi Ospedale Niguarda Cà Granda, Milano
    Minerva Anestesiol 66:3-23. 2000
  7. ncbi request reprint The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications
    F Baudo
    Hemostasis and Thrombosis Unit, Niguarda Hospital, Milan, Italy
    Thromb Res 99:21-4. 2000
  8. ncbi request reprint Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis
    F Baudo
    Haemostasis and Thrombosis Unit and Liver Transplantation Center, Niguarda Hospital, Milan, Italy
    Haemophilia 5:276-7. 1999
  9. ncbi request reprint Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice
    Francesco Baudo
    Thrombosis and Hemostasis Unit, Nigurda Hospital, Milan, Italy
    BJOG 110:311-4. 2003
  10. doi request reprint Diagnosis, laboratory aspects and management of acquired hemophilia A
    Vincenzo Toschi
    Servizio di Immunoematologia e Trasfusione, Centro Emostasi e Trombosi, AO Ospedale San Carlo Borromeo, Via Pio II, 3, 20153, Milan, Italy
    Intern Emerg Med 5:325-33. 2010

Detail Information

Publications15

  1. doi request reprint Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
    Francesco Baudo
    Thrombosis and Hemostasis Unit, Ospedale Niguarda, Milan, Italy
    Blood 120:39-46. 2012
    ..3% vs 68.3%; P = .003). Bleeding control was similar between rFVIIa and aPCC (93.0%; P = 1). Thrombotic events were reported in 3.6% of treated patients with a similar incidence between rFVIIa (2.9%) and aPCC (4.8%)...
  2. pmc Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
    Peter Collins
    Arthur Bloom Hemophilia centre, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK
    BMC Res Notes 3:161. 2010
    ..AHA usually presents to clinicians without prior experience of the disease, therefore diagnosis is frequently delayed and bleeds under treated...
  3. ncbi request reprint "Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue
    Francesco Baudo
    Haemostasis and Thrombosis Unit, Niguarda Ca Granda Hospital, Milan, Italy
    Intern Emerg Med 1:94-5. 2006
  4. ncbi request reprint Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study
    F Baudo
    Department of Hematology, Ospedale Niguarda, Milano, Italy
    Intensive Care Med 24:336-42. 1998
    ..The efficacy of ATIII therapy on mortality was assessed in a selected group of patients admitted to the intensive care unit (ICU) in a double-blind, randomized, multicenter study...
  5. ncbi request reprint Acquired hemophilia: a critical bleeding syndrome
    Francesco Baudo
    Department of Hematology and Thrombosis Hemostasis Unit, Niguarda Hospital, Milan, Italy
    Haematologica 89:96-100. 2004
  6. ncbi request reprint [Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects]
    F Baudo
    Modulo Trombosi ed Emostasi Ospedale Niguarda Cà Granda, Milano
    Minerva Anestesiol 66:3-23. 2000
    ..All these data suggest severe sepsis and septic shock as main criteria for treatment...
  7. ncbi request reprint The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications
    F Baudo
    Hemostasis and Thrombosis Unit, Niguarda Hospital, Milan, Italy
    Thromb Res 99:21-4. 2000
    ..These variations observed during the infusion period were not accompanied by clinical events...
  8. ncbi request reprint Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis
    F Baudo
    Haemostasis and Thrombosis Unit and Liver Transplantation Center, Niguarda Hospital, Milan, Italy
    Haemophilia 5:276-7. 1999
    ..At the time of reporting the patient has a normal working life. FVIII plasma concentration is normal. The indirect hyperbilirubinaemia may be related to the Gilbert's anomaly of the donor...
  9. ncbi request reprint Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice
    Francesco Baudo
    Thrombosis and Hemostasis Unit, Nigurda Hospital, Milan, Italy
    BJOG 110:311-4. 2003
    ..To review the clinical problems related to the inhibitor of factor VIII (FVIII) in pregnancy...
  10. doi request reprint Diagnosis, laboratory aspects and management of acquired hemophilia A
    Vincenzo Toschi
    Servizio di Immunoematologia e Trasfusione, Centro Emostasi e Trombosi, AO Ospedale San Carlo Borromeo, Via Pio II, 3, 20153, Milan, Italy
    Intern Emerg Med 5:325-33. 2010
    ..Other treatments including Rituximab, immunoadsorption or induction of immune tolerance are still experimental, and need to be validated through controlled clinical trials...
  11. ncbi request reprint Prothrombin A19911G polymorphism and the risk of venous thromboembolism
    I Martinelli
    Department of Internal Medicine and Medical Specialties, A Bianchi Bonomi Haemophilia and Thrombosis Center, University of Milan, and IRCCS Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena Foundation, Milan, Italy
    J Thromb Haemost 4:2582-6. 2006
    ..The A > G polymorphism at position 19911 of the prothrombin gene is associated with increased plasma prothrombin levels but its role as a risk factor for venous thromboembolism (VTE) is not established...
  12. ncbi request reprint Hemophilia and percutaneous coronary interventions
    Antonio Mafrici
    Ital Heart J 4:731-3. 2003
  13. doi request reprint Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations
    Andreas Tiede
    Hannover Medical School, Dept of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Germany
    Thromb Haemost 99:616-22. 2008
    ..In conclusion, this study suggests that antithrombin alfa is a safe and effective alternative to human plasma-derived AT for treating hereditary AT deficiency patients at high risk for thromboembolic events...
  14. ncbi request reprint Drug-induced anti-factor VIII antibodies: a systematic review
    Massimo Franchini
    Servizio di Immunoematologia e Trasfusione Centro Emofilia, Azienda Ospedaliera di Verona, Verona, Italy
    Med Sci Monit 13:RA55-61. 2007
    ..3%). However, further studies are needed to better elucidate the epidemiology, natural history, clinical relevance, and optimal treatment of drug-associated factor VIII autoantibodies...
  15. ncbi request reprint Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia
    Francesco Baudo
    Haematologica 89:759-61. 2004
    ..Bleeding was controlled in 90% of the episodes, indicating the efficacy of rFVIIa in HA...